 | • レポートコード：MRC2301F0061 • 出版社/出版日：Transparency Market Research / 2022年10月10日 • レポート形態：英文、PDF、163ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥811,300 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,231,300 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,651,300 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の当調査資料では、世界のホメオパシー製品市場について総合的に調査・分析を行い、序論、仮定・調査手法、市場概要、主要インサイト、製品別（チンキ剤、希釈剤、バイオケミカル、軟膏剤、その他）分析、ソース別（植物、動物、ミネラル）、用途別（鎮痛＆解熱、呼吸器、神経、免疫、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）分析、競争状況、企業情報などの項目を掲載しています。なお、当市場の主要企業には、Boiron、Dr. Reckeweg & Co. GmbH、Hyland's、Hahnemann Laboratories Inc.、Dr. Willmar Schwabe GmbH & Co. KG、Biologische Heilmittel Heel GmbH、Homeocan, Inc.、Ainsworths (London) Limited、PEKANA、SBL Pvt. Ltd.などが含まれています。 ・序論 ・仮定・調査手法 ・市場概要 ・主要インサイト ・世界のホメオパシー製品市場規模：製品別 - チンキ剤の市場規模 - 希釈剤の市場規模 - バイオケミカルの市場規模 - 軟膏剤の市場規模 - その他製品の市場規模 ・世界のホメオパシー製品市場規模：ソース別 - 植物由来の市場規模 - 動物由来の市場規模 - ミネラル由来の市場規模 ・世界のホメオパシー製品市場規模：用途別 - 鎮痛＆解熱における市場規模 - 呼吸器における市場規模 - 神経における市場規模 - 免疫における市場規模 - その他用途における市場規模 ・世界のホメオパシー製品市場規模：地域別 - 北米のホメオパシー製品市場規模 - 中南米のホメオパシー製品市場規模 - ヨーロッパのホメオパシー製品市場規模 - アジア太平洋のホメオパシー製品市場規模 - 中東/アフリカのホメオパシー製品市場規模 ・競争状況 ・企業情報 |
Homeopathic Products Market – Scope of Report
TMR’s report on the global homeopathic products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global homeopathic products market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global homeopathic products market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the homeopathic products market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global homeopathic products market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global homeopathic products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global homeopathic products market.
The report delves into the competitive landscape of the global homeopathic products market. Key players operating in the global homeopathic products market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global homeopathic products market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market homeopathic products.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Homeopathic Products Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Homeopathic Products Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key industry events (mergers & acquisitions, partnerships, product launches etc.)
5.2. Technological advancements
5.3. Regulatory scenario by Region/globally
6. Global Homeopathic Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Tincture
6.3.2. Dilutions
6.3.3. Bio-chemic
6.3.4. Ointment
6.3.5. Tablet
6.3.6. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Homeopathic Products Market Analysis and Forecast, by Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Source, 2017–2031
7.3.1. Plants
7.3.2. Animals
7.3.3. Minerals
7.4. Market Attractiveness Analysis, by Source
8. Global Homeopathic Products Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Analgesic & Antipyretic
8.3.2. Respiratory
8.3.3. Neurology
8.3.4. Immunology
8.3.5. Gastroenterology
8.3.6. Dermatology
8.3.7. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Homeopathic Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Homeopathic Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Tincture
10.2.2. Dilutions
10.2.3. Bio-chemic
10.2.4. Ointment
10.2.5. Tablet
10.2.6. Others
10.3. Market Value Forecast, by Source, 2017–2031
10.3.1. Plants
10.3.2. Animals
10.3.3. Minerals
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Analgesic & Antipyretic
10.4.2. Respiratory
10.4.3. Neurology
10.4.4. Immunology
10.4.5. Gastroenterology
10.4.6. Dermatology
10.4.7. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Source/p>
10.6.3. By Application
10.6.4. By Country
11. Europe Homeopathic Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Tincture
11.2.2. Dilutions
11.2.3. Bio-chemic
11.2.4. Ointment
11.2.5. Tablet
11.2.6. Others
11.3. Market Value Forecast, by Source, 2017–2031
11.3.1. Plants
11.3.2. Animals
11.3.3. Minerals
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Analgesic & Antipyretic
11.4.2. Respiratory
11.4.3. Neurology
11.4.4. Immunology
11.4.5. Gastroenterology
11.4.6. Dermatology
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Source
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Homeopathic Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Tincture
12.2.2. Dilutions
12.2.3. Bio-chemic
12.2.4. Ointment
12.2.5. Tablet
12.2.6. Others
12.3. Market Value Forecast, by Source, 2017–2031
12.3.1. Plants
12.3.2. Animals
12.3.3. Minerals
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Analgesic & Antipyretic
12.4.2. Respiratory
12.4.3. Neurology
12.4.4. Immunology
12.4.5. Gastroenterology
12.4.6. Dermatology
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Source
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Homeopathic Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Tincture
13.2.2. Dilutions
13.2.3. Bio-chemic
13.2.4. Ointment
13.2.5. Tablet
13.2.6. Others
13.3. Market Value Forecast, by Source, 2017–2031
13.3.1. Plants
13.3.2. Animals
13.3.3. Minerals
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Analgesic & Antipyretic
13.4.2. Respiratory
13.4.3. Neurology
13.4.4. Immunology
13.4.5. Gastroenterology
13.4.6. Dermatology
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Source
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Homeopathic Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Tincture
14.2.2. Dilutions
14.2.3. Bio-chemic
14.2.4. Ointment
14.2.5. Tablet
14.2.6. Others
14.3. Market Value Forecast, by Source, 2017–2031
14.3.1. Plants
14.3.2. Animals
14.3.3. Minerals
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Analgesic & Antipyretic
14.4.2. Respiratory
14.4.3. Neurology
14.4.4. Immunology
14.4.5. Gastroenterology
14.4.6. Dermatology
14.4.7. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Source
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. BOIRON
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Dr. Reckeweg & Co. GmbH
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Hyland’s
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Hahnemann Laboratories, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Dr. Willmar Schwabe GmbH & Co. KG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Biologische Heilmittel Heel GmbH
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Homeocan, Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Ainsworths (London) Limited
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. PEKANA
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. SBL Pvt. Ltd
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview